Skip to content

The safety study of a supplement containing chicken breast meat extract supplements for healthy volunteer with long-term ingestion

The safety study of a supplement containing chicken breast meat extract supplements for healthy volunteer with long-term ingestion - The safety study of a supplement containing chicken breast meat extract supplements for healthy volunteer with long-term ingestion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020056
Enrollment
10
Registered
2017-04-02
Start date
2015-12-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteer

Interventions

This study examines the safety of a supplement containing chicken breast meat extract for 12 weeks with long-term ingestion.

Sponsors

TTC Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Japanese healthy males and females aged 20-64 years

Exclusion criteria

Exclusion criteria: (1) Subjects who routinely use health food containing plasmalogens, imidazole dipeptide, and ferlic acid. (2) Subjects who have under treatment or a history of serious disease (3) Subjects who using medical products, and subjects who have a history of serious disease. (4) Subjects having possibilities for emerging allergy related to the study (5) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (6) Subjects who are judged as unsuitable for the current study based on the results of lifestyle questionnaire (7) Subjects who have participated in other clinical studies within the last one month prior to the current study or are planned to participate in other studies after obtaining informed consent for the current study (8) Subjects who intend to become pregnant or lactating (9) Subjects judged as unsuitable for the current study by the investigator

Design outcomes

Primary

MeasureTime frame
Hematologic test Blood biochemistry test Urine analysis Blood pressure/pulsation Weight Doctor's questions Adverse event

Countries

Japan

Contacts

Public ContactNoriko Watanabe

TTC Co.,Ltd. Clinical Research Planning Department

n.watanabe@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026